Tocagen – $98 Million IPO

San Diego – April 20, 2017 – Cooley advised Tocagen on its $97.8 million initial public offering of 9,775,000 shares of common stock.

San Diego-based Tocagen, which trades on The NASDAQ Global Select Market as “TOCA,” is a clinical-stage, cancer-selective gene therapy company developing first-in-class, broadly applicable product candidates designed to activate a patient’s immune system against their own cancer.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.

Cooley has 900 lawyers across 12 offices in the United States, China and Europe.

Related Contacts
Fred Muto  Senior Counsel San Diego
Ken Rollins  Partner San Diego
Karen Deschaine  Partner San Diego
Wade Andrews  Associate San Diego
Jessica Wade  Paralegal Specialist San Diego
Natasha Leskovsek  Of Counsel Washington, DC
Phil Mitchell  Partner New York
Megan Arthur Schilling  Partner San Diego
Dani Nazemian  Associate San Diego
Susan Cooper Philpot  Retired Partner San Francisco